Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: Systemic Lupus Erythematosus

TYK2 inhibition shows potential as a treatment for SLE

Presented By
Dr Marilyn Pike, MedPharm Consulting, MA, USA
Trial
Phase 2, PAISLEY
Conference
ACR 2022

1 December, 2022 12:19

Inhibition of Bruton’s tyrosine kinase: a new way of approaching SLE?

Presented By
Prof. Zangou Li , Peking University People’s Hospital, China
Conference
EULAR 2022

21 July, 2022 19:21

Pregnancies in SLE: many complications for mothers and their unborn children

Presented By
Prof. Bella Mehta , Weill Cornell Medical College, NY, USA
Conference
EULAR 2022

21 July, 2022 19:16

Lupus nephritis: Efficient treatment may reduce the risk of kidney disease advancement

Presented By
Prof. Konstantinos Tselios , McMaster University, Canada
Conference
EULAR 2022

21 July, 2022 18:10

TYK2 inhibition: the future of treating lupus erythematosus?

Presented By
Prof. Eric Morand , Monash University, Australia
Trial
Phase 2, PAISLEY
Conference
EULAR 2022

21 July, 2022 14:45

EULAR 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
EULAR 2022

22 June, 2022 23:51

Kidney disease and hydroxychloroquine dose are risk factors for developing retinopathy

Presented By
Dr April Jorge, Massachusetts General Hospital, MA, USA
Conference
ACR 2021

14 January, 2022 10:55

Vaccinated rheumatic patients carry increased risk for COVID-19 breakthrough infections

Presented By
Prof. Jasvinder Singh, University of Alabama at Birmingham, AL, USA
Conference
ACR 2021

14 January, 2022 10:47

B-cell depleting medication increases COVID-19 breakthrough infection outcome risk

Presented By
Prof. Jean Liew, Boston University, MA, USA
Conference
ACR 2021

14 January, 2022 10:45

COVID-19 mRNA vaccine safe and tolerable in adults with autoimmune disease

Presented By
Dr Inés Colmegna, McGill University Health Centre, Canada
Conference
ACR 2021

14 January, 2022 10:06

Iberdomide: an upcoming new treatment possibility in lupus erythematosus

Presented By
Prof. Joan Merrill, Oklahoma Medical Research Foundation, OK, USA
Trial
Phase 2
Conference
ACR 2021

14 January, 2022 10:04

Sequential rituximab after belimumab does not improve disease control in SLE

Presented By
Prof. Cynthia Aranow, Feinstein Institutes for Medical Research, NY, USA
Trial
Phase 3, BLISS-BELIEVE
Conference
ACR 2021

14 January, 2022 10:02

Lupus patients less protected by COVID-19 vaccine

Presented By
Dr Peter Izmirly, New York University Grossman School of Medicine, NY, USA
Conference
ACR 2021

14 January, 2022 10:00

Paediatric dermatology in Tunisia: common diagnoses

Presented By
Dr Nejib Doss, Military Hospital of Tunis, Tunisia
Conference
ICD 2021

2 December, 2021 17:08

Systemic lupus erythematosus: increased risk of severe infection

Presented By
Mr Kai Zhao, Simon Fraser University, Canada
Conference
EULAR 2021

2 August, 2021 18:31

Fenebrutinib at highest dose generally well tolerated

Conference
AAN 2021

16 June, 2021 11:49

No heightened outcome risk for rheumatic patients with COVID-19

Presented By
Dr Naomi Serling-Boyd, Massachusetts General Hospital, USA
Conference
ACR 2020

18 January, 2021 10:56

Lupus nephritis biomarkers: moving toward an omic-driven approach

Presented By
Prof. Chaim Putterman, Albert Einstein College of Medicine, USA
Conference
ACR 2020

18 January, 2021 10:54

Lupus nephritis: new therapies on the horizon in 2020

Presented By
Prof. Joan T. Merrill, Oklahoma Medical Research Foundation, USA
Conference
ACR 2020

18 January, 2021 10:54

Inflammatory disease as a risk factor for fractures

Presented By
Dr Giovanni Adami, University of Verona, Italy
Conference
ACR 2020

18 January, 2021 10:45

Hydroxychloroquine use: no indication for arrhythmias in RA and SLE patients

Presented By
Dr Elizabeth Park, Columbia University Irving Medical Center, USA
Conference
ACR 2020

18 January, 2021 10:41

Children with rheumatic disease have no greater risk of a COVID-19 infection

Presented By
Dr Jonathan S. Hausmann, Harvard Medical School and Boston Children’s Hospital, USA
Conference
ACR 2020

18 January, 2021 10:40

Anifrolumab achieves rapid and durable BICLA-response

Presented By
Prof. Eric Morand, Monash University, Australia
Trial
TULIP-1, TULIP-2
Conference
EULAR 2020

14 August, 2020 15:01

Wide variation in prescription and dosing patterns for hydroxychloroquine in SLE

Conference
EULAR 2020

14 August, 2020 14:52

HS patients carry higher risk for systemic lupus erythematosus

Trial
phase 1
Conference
AAD 2020

6 August, 2020 13:04

Anifrolumab succeeds in second phase 3 trial in SLE

Presented By
Prof. Eric Morand, Prof. Richard Furie
Trial
Phase 3, TULIP
Conference
ACR 2019

4 February, 2020 23:44

Prevention of congenital heart block may be possible with hydroxychloroquine

Presented By
Prof. Peter Izmirly, New York University School of Medicine, USA
Trial
PATCH
Conference
ACR 2019

4 February, 2020 22:14

Depression closely related to fatigue in SLE patients

Presented By
Christina Düsing, Universitätsklinikum Düsseldorf, Germany
Conference
ACR 2019

4 February, 2020 12:47

New targets and biologics for cutaneous lupus erythematosus

Presented By
Prof. Victoria P. Werth, University of Pennsylvania, USA
Conference
WCD 2019

26 August, 2019 15:59

Novel lupus classification will aid future research

Presented By
Prof. Joseph F. Merola, Brigham and Women´s Hospital, Harvard Medical School, USA
Conference
WCD 2019

26 August, 2019 11:02

Systemic lupus erythematosus: Baricitinib may be potential therapy, and clinical benefit of ustekinumab

Conference
EULAR 2018

24 August, 2018 20:52
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy